IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v52y2023i4s0048733323000239.html
   My bibliography  Save this article

Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions

Author

Listed:
  • Fonseca, Elize Massard da
  • Shadlen, Kenneth C.
  • Achcar, Helena de Moraes

Abstract

The COVID-19 pandemic, which featured international pharmaceutical firms seeking to build global manufacturing networks to scale-up the supply of vaccines, has generated heightened interest in understanding the role of firm-to-firm technology transfer. While considerable attention has been given to tracking the extent of international vaccine technology transfer, we know little about how partnerships were established and work in practice. Understanding the challenges that such projects face, and how such challenges may be overcome, is crucially important. This paper provides an account of the partnership between the British-Swedish multinational pharmaceutical company AstraZeneca, the vaccine developer that has engaged in the most technology transfer and built the widest global manufacturing network, and Bio-Manguinhos, a public laboratory linked to Brazil's Ministry of Health. The case study demonstrates the importance of capabilities and regulatory flexibility. Moreover, the analysis highlights the role of political factors that affect the process of technology transfer, and innovation more broadly. Because of the risks involved and the need to quickly mobilize existing capabilities and build new ones, as well as the imperatives of coordinating among manufacturing and regulatory processes and allocating resources to make such arrangements feasible, technology transfer projects need to be enabled politically. Looking forward, the case study has implications for initiatives to expand technology transfer for broadened production of vaccines in the Global South.

Suggested Citation

  • Fonseca, Elize Massard da & Shadlen, Kenneth C. & Achcar, Helena de Moraes, 2023. "Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions," Research Policy, Elsevier, vol. 52(4).
    • Handle: RePEc:eee:respol:v:52:y:2023:i:4:s0048733323000239
    DOI: 10.1016/j.respol.2023.104739
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0048733323000239
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.respol.2023.104739?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Jean O. Lanjouw, 2003. "Intellectual Property and the Availability of Pharmaceuticals in Poor Countries," NBER Chapters, in: Innovation Policy and the Economy, Volume 3, pages 91-130, National Bureau of Economic Research, Inc.
    2. Joanna Chataway & Stefano Brusoni & Eugenia Cacciatori & Rebecca Hanlin & Luigi Orsenigo, 2007. "The International AIDS Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator," The European Journal of Development Research, Taylor and Francis Journals, vol. 19(1), pages 100-117.
    3. Edquist, Charles & Zabala-Iturriagagoitia, Jon Mikel, 2012. "Public Procurement for Innovation as mission-oriented innovation policy," Research Policy, Elsevier, vol. 41(10), pages 1757-1769.
    4. Chad P. Bown & Thomas J. Bollyky, 2022. "How COVID‐19 vaccine supply chains emerged in the midst of a pandemic," The World Economy, Wiley Blackwell, vol. 45(2), pages 468-522, February.
    5. Uyarra, Elvira & Zabala-Iturriagagoitia, Jon Mikel & Flanagan, Kieron & Magro, Edurne, 2020. "Public procurement, innovation and industrial policy: Rationales, roles, capabilities and implementation," Research Policy, Elsevier, vol. 49(1).
    6. Chataway, Joanna & Hanlin, Rebecca & Mugwagwa, Julius & Muraguri, Lois, 2010. "Global health social technologies: Reflections on evolving theories and landscapes," Research Policy, Elsevier, vol. 39(10), pages 1277-1288, December.
    7. Xiaolan Fu & Peter J. Buckley & Diego Sanchez-Ancochea & Ines Hassan, 2022. "The world has a unique opportunity: Accelerating technology transfer and vaccine production through partnerships," Journal of International Business Policy, Palgrave Macmillan, vol. 5(3), pages 406-415, September.
    8. Yaqub, Ohid & Nightingale, Paul, 2012. "Vaccine innovation, translational research and the management of knowledge accumulation," Social Science & Medicine, Elsevier, vol. 75(12), pages 2143-2150.
    9. Amy Maxmen, 2021. "The fight to manufacture COVID vaccines in lower-income countries," Nature, Nature, vol. 597(7877), pages 455-457, September.
    10. Maurice Cassier & Marilena Correa, 2003. "Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs," Post-Print halshs-02162784, HAL.
    11. Crager, S.E., 2014. "Improving global access to new vaccines: Intellectual property, technology transfer, and regulatory pathways," American Journal of Public Health, American Public Health Association, vol. 104(11), pages 85-91.
    12. S. Agarwal & Ashwani Gupta & R. Dayal, 2007. "Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)," The Journal of Technology Transfer, Springer, vol. 32(4), pages 397-423, August.
    13. Ramani, Shyama V. & Urias, Eduardo, 2018. "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil," Research Policy, Elsevier, vol. 47(8), pages 1538-1552.
    14. Fonseca, Elize Massard da & Shadlen, Kenneth C. & Bastos, Francisco I., 2021. "The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil," Social Science & Medicine, Elsevier, vol. 281(C).
    15. Thomas J. Bollyky & Jennifer Nuzzo & Noelle Huhn & Samantha Kiernan & Emily Pond, 2022. "Global vaccination must be swifter," Nature, Nature, vol. 603(7903), pages 788-792, March.
    16. Shiri Mermelstein & Hilde Stevens, 2022. "TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines," ULB Institutional Repository 2013/337220, ULB -- Universite Libre de Bruxelles.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Paola Perez-Aleman & Tommaso Ferretti, 2023. "Creating innovation capabilities for improving global health: Inventing technology for neglected tropical diseases in Brazil," Journal of International Business Policy, Palgrave Macmillan, vol. 6(1), pages 84-114, March.
    2. Ohid Yaqub, 2018. "Variation in the dynamics and performance of industrial innovation: what can we learn from vaccines and HIV vaccines?," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(1), pages 173-187.
    3. Yaqub, Ohid, 2017. "Testing regimes in clinical trials: Evidence from four polio vaccine trajectories," Research Policy, Elsevier, vol. 46(2), pages 475-484.
    4. Zabala-Iturriagagoitia, Jon Mikel & Aparicio, Juan & Ortiz, Lidia & Carayannis, Elias G. & Grigoroudis, Evangelos, 2021. "The productivity of national innovation systems in Europe: Catching up or falling behind?," Technovation, Elsevier, vol. 102(C).
    5. Woodson, Thomas S., 2016. "Public private partnerships and emerging technologies: A look at nanomedicine for diseases of poverty," Research Policy, Elsevier, vol. 45(7), pages 1410-1418.
    6. Selviaridis, Kostas & Hughes, Alan & Spring, Martin, 2023. "Facilitating public procurement of innovation in the UK defence and health sectors: Innovation intermediaries as institutional entrepreneurs," Research Policy, Elsevier, vol. 52(2).
    7. Yunjuan Liang & Xin Liang & Hua Wei, 2023. "Sustainable Quality-Incentive Contract Design of Public Technology Innovation Procurement under Asymmetry Information," Sustainability, MDPI, vol. 15(11), pages 1-22, May.
    8. Dai, Xiaoyong & Li, Yanchao & Chen, Kaihua, 2021. "Direct demand-pull and indirect certification effects of public procurement for innovation," Technovation, Elsevier, vol. 101(C).
    9. Edquist, Charles & Zabala-Iturriagagoitia, Jon Mikel, 2020. "Functional procurement for innovation, welfare and the environment," Papers in Innovation Studies 2020/1, Lund University, CIRCLE - Centre for Innovation Research, revised 19 Jul 2020.
    10. Cao, Wanpeng & Du, Debin & Xia, Qifan, 2023. "Unbalanced global vaccine product trade pattern: A network perspective," Social Science & Medicine, Elsevier, vol. 325(C).
    11. Stojčić, Nebojša & Srhoj, Stjepan & Coad, Alex, 2020. "Innovation procurement as capability-building: Evaluating innovation policies in eight Central and Eastern European countries," European Economic Review, Elsevier, vol. 121(C).
    12. Coburn, Josie & Yaqub, Ohid & Chataway, Joanna, 2022. "Targeting research to address societal needs: What can we learn from 30 years of targeting neglected diseases?," SocArXiv 65ws7, Center for Open Science.
    13. Jessica Catalano & Francesco Giffoni & Paolo Castelnovo, 2021. "The impact of space procurement on suppliers: Evidence from Italy," Working Papers 202102, CSIL Centre for Industrial Studies.
    14. Il-haam Petersen, 2016. "Achieving Co-Operation in an Aid-Funded Development Network Organisation (DNO): Lessons for Development Practitioners," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 28(5), pages 916-933, November.
    15. Mwesiumo, Deodat & Glavee-Geo, Richard & Olsen, Kjetil Magnus & Svenning, Geir Arne, 2021. "Improving public purchaser attitudes towards public procurement of innovations," Technovation, Elsevier, vol. 101(C).
    16. Kalyuzhnova, Yelena & Azhgaliyeva, Dina & Belitski, Maksim, 2022. "Public Policy Instruments for Procurement: An Empirical Analysis," Technological Forecasting and Social Change, Elsevier, vol. 176(C).
    17. Polzin, Friedemann & von Flotow, Paschen & Klerkx, Laurens, 2016. "Addressing barriers to eco-innovation: Exploring the finance mobilisation functions of institutional innovation intermediaries," Technological Forecasting and Social Change, Elsevier, vol. 103(C), pages 34-46.
    18. Matthijs Jansen, 2022. "Legitimation and Effects of Mission-Oriented Innovation Policies: A Spillover Perspective," Hacienda Pública Española / Review of Public Economics, IEF, vol. 243(4), pages 7-28, December.
    19. Liotard, Isabelle & Revest, Valérie, 2018. "Contests as innovation policy instruments: Lessons from the US federal agencies' experience," Technological Forecasting and Social Change, Elsevier, vol. 127(C), pages 57-69.
    20. Janssen, Matthijs J. & Abbasiharofteh, Milad, 2022. "Boundary spanning R&D collaboration: Key enabling technologies and missions as alleviators of proximity effects?," Technological Forecasting and Social Change, Elsevier, vol. 180(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:52:y:2023:i:4:s0048733323000239. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.